Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger L Williams

Showing results (31-40 of 127) with videos related to

Pageof 13
Sort By:
Clinical Pharmacology and Therapeutics|September 18, 2002
Equivalence approachesRoger L Williams, Mei-Ling Chen, Walter W Hauck
Methods in Molecular Biology (Clifton, N.J.)|April 2, 2016
Methods in the Study of PTEN Structure: X-Ray Crystallography and Hydrogen Deuterium Exchange Mass SpectrometryGlenn R Masson, John E Burke, Roger L Williams
The Biochemical Journal|April 7, 2017
Analysis of phosphoinositide 3-kinase inhibitors by bottom-up electron-transfer dissociation hydrogen/deuterium exchange mass spectrometryGlenn R Masson, Sarah L Maslen, Roger L Williams
Pharmaceutical Research|May 30, 2002
Content uniformity and dose uniformity: current approaches, statistical analyses, and presentation of an alternative approach, with special reference to oral inhalation and nasal drug productsRoger L Williams, Wallace P Adams, Guirag Poochikian, et al.
Food and Drug Law Journal|July 16, 2009
FDA's dietary supplement CGMPs: standards without standardizationRuth K Miller, Carlos Celestino, Gabriel I Giancaspro, et al.
Chemical Communications (Cambridge, England)|April 11, 2008
The barrier to enantiomerization of N-Boc-2-lithiopyrrolidine: the effect of chiral and achiral diaminesTaher I Yousaf, Roger L Williams, Iain Coldham, et al.
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|April 3, 2002
Lack of medication dose uniformity in commonly split tabletsJaja Teng, Clara K Song, Roger L Williams, et al.
Oncotarget|January 19, 2013
PI3Kβ downstream of GPCRs - crucial partners in oncogenesisHashem A Dbouk, Oscar Vadas, Roger L Williams, et al.
The Biochemical Journal|November 4, 2015
The intrinsically disordered tails of PTEN and PTEN-L have distinct roles in regulating substrate specificity and membrane activityGlenn R Masson, Olga Perisic, John E Burke, et al.
The AAPS Journal|April 18, 2014
Progressively reducing regulatory burdenVinod P Shah, Todd L Cecil, Srini V Srinivasan, et al.
Pageof 13

Showing results (31-40 of 127) with videos related to

Sort By:
Pageof 13
Clinical Pharmacology and Therapeutics|September 18, 2002
Equivalence approachesRoger L Williams, Mei-Ling Chen, Walter W Hauck
Methods in Molecular Biology (Clifton, N.J.)|April 2, 2016
Methods in the Study of PTEN Structure: X-Ray Crystallography and Hydrogen Deuterium Exchange Mass SpectrometryGlenn R Masson, John E Burke, Roger L Williams
The Biochemical Journal|April 7, 2017
Analysis of phosphoinositide 3-kinase inhibitors by bottom-up electron-transfer dissociation hydrogen/deuterium exchange mass spectrometryGlenn R Masson, Sarah L Maslen, Roger L Williams
Pharmaceutical Research|May 30, 2002
Content uniformity and dose uniformity: current approaches, statistical analyses, and presentation of an alternative approach, with special reference to oral inhalation and nasal drug productsRoger L Williams, Wallace P Adams, Guirag Poochikian, et al.
Food and Drug Law Journal|July 16, 2009
FDA's dietary supplement CGMPs: standards without standardizationRuth K Miller, Carlos Celestino, Gabriel I Giancaspro, et al.
Chemical Communications (Cambridge, England)|April 11, 2008
The barrier to enantiomerization of N-Boc-2-lithiopyrrolidine: the effect of chiral and achiral diaminesTaher I Yousaf, Roger L Williams, Iain Coldham, et al.
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|April 3, 2002
Lack of medication dose uniformity in commonly split tabletsJaja Teng, Clara K Song, Roger L Williams, et al.
Oncotarget|January 19, 2013
PI3Kβ downstream of GPCRs - crucial partners in oncogenesisHashem A Dbouk, Oscar Vadas, Roger L Williams, et al.
The Biochemical Journal|November 4, 2015
The intrinsically disordered tails of PTEN and PTEN-L have distinct roles in regulating substrate specificity and membrane activityGlenn R Masson, Olga Perisic, John E Burke, et al.
The AAPS Journal|April 18, 2014
Progressively reducing regulatory burdenVinod P Shah, Todd L Cecil, Srini V Srinivasan, et al.
Pageof 13